Spoor Johan M.
SEC insider (Form 3/4/5 filer). CIK 0001535289. Chief Executive Officer at Perspective Therapeutics, Inc. (CATX). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.
Companies Spoor Johan M. has filed insider reports for
- Perspective Therapeutics, Inc. (CATX): Director, Officer, Chief Executive Officer
Spoor Johan M.
CIK: 0001535289
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Perspective Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 2, 2026CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
735K shares- - Mar 28, 2025CATX
Perspective Therapeutics, Inc.
PurchaseDirect22K shares at avg. $2.24$49K - Mar 28, 2025CATX
Perspective Therapeutics, Inc.
PurchaseIndirect4.7K shares at avg. $2.21$10K - Mar 3, 2025CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
650K shares- - Dec 4, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect8K shares at avg. $3.77$30K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect14.5K shares at avg. $3.78$55K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseIndirect5.4K shares at avg. $3.80$21K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseIndirect6.6K shares at avg. $3.80$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 735,000 | - | - | Direct |
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | Purchase | 22,026 | $2.24 | $49,384 | Direct |
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | Purchase | 4,650 | $2.21 | $10,288 | Indirect |
| Mar 3, 2025 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 650,000 | - | - | Direct |
| Dec 4, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 8,000 | $3.77 | $30,132 | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 14,500 | $3.78 | $54,868 | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 5,400 | $3.80 | $20,520 | Indirect |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 6,600 | $3.80 | $25,080 | Indirect |
1-8 of 8 transactions